Wall Street researchers just used Claude to design a drug. The experiment has spawned a new investment thesis.
For years, artificial-intelligence evangelists have boasted about the technology’s capacity to revolutionize drug development and medical research.
Source：MarketWatch
友情提醒：請廣大讀者理性看待市場資訊，切實提高風險意識。站內所有內容僅系市場資訊或相關方觀點，不構成任何形式投資建議。